Alcide Barberis

Dr. Alcide Barberis is a biotech entrepreneur and manager with over 20 years of management experience in the biotechnology industry and scientific experience in the private and public research sectors. He is currently CEO of Mabylon AG and was previously CEO of Humabs BioMed, now a subsidiary of VIR Biotechnology.

His career includes entrepreneurial start-ups (co-founder of ESBATech AG and Oncalis AG), executive management, R&D management and business development. Dr. Barberis has been a member of the Board of Directors of ESBATech and Oncalis and is currently a member of the Board of Directors of Mabylon. In his roles as biotech manager, he successfully negotiated collaboration and licensing deals with pharma companies and contributed to fundraising campaigns with private investors and VCs.

Dr. Barberis holds a Ph.D. in Molecular Biology and Biochemistry from the University of Zürich.